Near-infrared imaging using intravenous indocyanine green to locate pulmonary metastases

Near-infrared imaging using intravenous indocyanine green to locate pulmonary metastases - Near-infrared imaging using intravenous indocyanine green to locate pulmonary metastases

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs051180044

Enrollment

Registered

2019-01-31

Start date

2019-01-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary metastasis

Interventions

Twelve to 24 hours prior to the operations, patients will receive intravenous indocyanine green of 2 mg / kg through peripheral veins in the patients' room. In the operating rooms, patients will under

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo pulmonary metastasectomies for palpable lesions.

Exclusion criteria

Exclusion criteria: Patients who are allergic to indocyanine green or iodine, those who are 19 years old or younger, those with cognitive disorders, those with hepatic failure, those requiring preoperative computed tomography-guided marking or bronchoscopic marking.

Design outcomes

Primary

Measure	Time frame
Any complication from intravenous administration of indocyanine green. Intraoperative fluorescence in pulmonary metastatic nodules identified on preoperative radiologic imaging or in other nodules that were not identified on preoperative radiologic imaging.	—

Secondary

Measure	Time frame
Fluorescence from the cut surfaces of pulmonary metastatic nodules after surgical resection	—

Contacts

Public ContactMasatsugu Hamaji

Kyoto University Hospital

mhamaji@kuhp.kyoto-u.ac.jp+81-75-751-4975

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026